Single-nucleus RNA sequencing (snRNA-seq) has changed what researchers can do with banked tissue. Instead of needing fresh samples — a logistical headache for multi-site studies, biobanks, and archived collections — snRNA-seq works with frozen tissue by isolating nuclei rather than whole cells. That difference matters for anyone sitting on a freezer full of specimens and wondering whether they are still usable.

But "works with frozen tissue" does not mean "any frozen tissue will work." Storage history, freeze-thaw events, tissue composition, and how the sample is handled before nuclei isolation all affect what comes out the other side. This article walks through what matters and what does not, so you can evaluate your samples before committing to a project.

For CD Genomics snRNA-seq services and feasibility review, visit: snRNA Sequencing Services

Can Frozen Tissue Work for snRNA-Seq?

Yes — and for many tissue types, frozen samples produce snRNA-seq data comparable to fresh samples. The key advantage is that nuclei are more resilient than whole cells. The nuclear membrane protects RNA from the enzymatic degradation that quickly destroys cytoplasmic RNA after thawing, and the nuclei isolation step removes much of the ambient RNA and debris that would otherwise dominate a single-cell preparation from frozen tissue.

Several large-scale studies have demonstrated this directly. Slyper et al. (2020) developed a systematic snRNA-seq toolbox for frozen clinical tumor samples and showed that nuclei from banked frozen specimens recovered cell-type proportions and transcriptional profiles consistent with matched fresh samples. Similarly, the S2 Genomics demonstrated protocol for nuclei isolation from frozen tissue lists validated tissue types — from brain and heart to kidney, liver, and adipose — with expected nuclei yields and quality metrics. For general nuclei isolation guidance, 10x Genomics provides best-practice protocols covering lysis, washing, debris removal, and counting steps applicable across tissue types.

The practical takeaway: if your samples were flash-frozen and stored at −80 °C without repeated thawing, the odds of usable snRNA-seq data are high. The sections below explain what can reduce those odds, and how to check before you ship.

Figure 1: Frozen tissue snRNA-seq workflow overview. Nuclei isolated from frozen tissue provide transcriptomic profiles without requiring fresh sample dissociation, making the approach suitable for archived and banked specimens.

Storage That Protects Nuclei

Not all frozen storage is equal. Three factors dominate nuclei preservation: temperature, duration, and freeze-thaw history.

Temperature. −80 °C is the standard for long-term tissue banking, and multiple studies confirm that RNA and DNA integrity remain stable at this temperature for years. Storage at −20 °C is riskier — enzymatic activity slows but does not stop, and RNA degradation accumulates over weeks to months. Liquid nitrogen vapor-phase storage (−150 °C to −196 °C) offers the best long-term preservation, though it is not strictly necessary for snRNA-seq if −80 °C storage has been consistent.

Duration. RNA remains surprisingly stable in frozen tissue over extended periods. A report from the Ontario Tumour Bank documented stable RNA integrity numbers (RIN) in tissue stored at cryogenic temperatures for over a decade. For snRNA-seq, nuclei quality matters more than RIN, but the principle holds: properly frozen tissue degrades slowly. The practical concern is usually not years in the freezer but what happened before freezing — prolonged warm ischemia before snap-freezing causes far more damage than years of cold storage.

Freeze-thaw history. This is where many banked samples fail. Each freeze-thaw cycle introduces ice crystal damage to membranes, releases nucleases, and increases the fraction of damaged or lysed nuclei. Kellman et al. (2021) quantified this: multiple freeze-thaw cycles caused measurable loss of consistency in RNA-seq tissue analysis, with transcriptional profiles shifting detectably after just two cycles. A sample thawed even briefly during a freezer malfunction or a power outage has undergone a partial cycle. If a sample's freeze-thaw history is unknown, it should be treated as higher risk.

Figure 2: Storage condition comparison. Consistent −80 °C storage preserves nuclei integrity; freeze-thaw cycles and warmer storage temperatures progressively degrade sample quality.

What Freeze-Thaw Does to Your Sample

The damage from freeze-thaw is not just about RNA degradation. It affects nuclei isolation itself. When ice crystals rupture cellular and nuclear membranes during thawing, the resulting debris — membrane fragments, released DNA, and protein aggregates — clogs filters, increases background in droplet-based platforms, and makes clean nuclei suspensions harder to obtain.

For snRNA-seq specifically, the practical consequences are:

• Lower nuclei yield. Damaged nuclei lyse during isolation and are lost before counting.
• More debris. Filter clogging and higher ambient RNA in the final suspension reduce data quality.
• Skewed cell-type recovery. Some cell types — particularly large or fragile ones like neurons and adipocytes — are disproportionately lost after freeze-thaw damage, potentially biasing the final dataset.

If freeze-thaw is suspected, the lab may need to adjust the nuclei isolation protocol — for example, adding a more aggressive debris-removal step or using a Percoll gradient instead of simple filtration. These adjustments are possible but add time and may reduce yield further. The best outcome starts with samples that have stayed frozen.

How Much Tissue Do You Need?

Tissue amount requirements for snRNA-seq are modest — typically 10–50 mg of frozen tissue is sufficient to yield the 5,000–10,000 nuclei that most droplet-based platforms target. This is roughly a 3–5 mm cube of solid tissue, or a single core from a tissue microarray.

However, the amount you should send depends on three things:

• Tissue cellularity. Dense, cell-rich tissues (liver, spleen, tumor) yield more nuclei per milligram than loose, matrix-rich tissues (adipose, fibrotic pancreas).
• Expected necrosis or damage. If the sample has visible necrotic regions — common in large clinical tumor specimens — you will need more starting material to compensate for the non-viable fraction.
• Protocol redundancy. Sending enough tissue for two isolation attempts (or at least a repeat if the first fails) is standard practice.

Table 1 provides rough starting-point guidelines.

Table 1: Suggested minimum frozen tissue amounts by tissue type

Guidelines adapted from 10x Genomics demonstrated protocols and published snRNA-seq studies.

These are ballpark numbers. A feasibility review with the processing lab is the most reliable way to confirm requirements for your specific tissue type and storage history.

Difficult Tissues: Fat, Fibrosis, and Necrosis

Some tissue types make nuclei isolation harder than others. Recognizing these challenges upfront helps set realistic expectations and allows the lab to adjust the protocol before starting.

Lipid-rich tissues (adipose, breast, fatty liver). Adipose tissue presents two problems for snRNA-seq. First, lipid droplets physically interfere with nuclei isolation — they float during centrifugation, trap nuclei, and reduce yield. Second, adipocytes themselves are fragile; their nuclei are often underrepresented in the final suspension. Whytock et al. (2023) published a detailed protocol for nuclei isolation from frozen human subcutaneous adipose tissue that addresses these issues with additional washing and filtration steps [7]. Expect lower nuclei counts per milligram than liver or tumor, and plan for 2–3× the tissue amount.

Fibrotic tissues (pancreatic cancer, cirrhotic liver, late-stage tumors). Dense extracellular matrix makes tissue hard to homogenize and traps nuclei during extraction. Extended enzymatic digestion is not an option for nuclei isolation (unlike single-cell preparations), so mechanical dissociation must be more aggressive — which risks shearing nuclei. A dounce homogenizer with controlled strokes, combined with gradient centrifugation for debris removal, generally works better than bead-based disruption for fibrotic samples.

Necrotic tissue. Necrotic regions in clinical tumor specimens contribute degraded RNA, DNA clumps, and debris that interfere with droplet-based platforms. If necrosis is visible on gross examination, dissect it away before freezing or before sending. If necrosis is diffuse and cannot be trimmed, flag it during feasibility review — the lab may recommend a debris-removal step and set a lower target for nuclei recovery.

What Good Nuclei Look Like

After isolation, nuclei quality determines whether sequencing is worth running. The two most commonly checked metrics are membrane integrity and the absence of clumps or debris.

Membrane integrity is typically assessed by fluorescent staining — trypan blue or a fluorescent nuclear dye such as DAPI or propidium iodide — followed by counting on a hemocytometer or automated cell counter. Intact nuclei appear as round, well-defined fluorescent bodies with smooth edges. Damaged nuclei appear irregular, dim, or fragmented. A target of >80% intact nuclei is reasonable for most frozen tissue snRNA-seq projects; >90% is achievable for well-preserved samples.

The second metric is clumping and debris. A clean nuclei suspension should be mostly single nuclei. Large clumps (>2–3 nuclei stuck together) increase the multiplet rate in droplet-based platforms and can clog microfluidics. Debris — visible as background fluorescent haze or non-nuclear particles — increases ambient RNA and reduces usable reads. A brief filtration step (30–40 μm strainer) or a low-speed centrifugation wash can often resolve mild clumping or debris.

Figure 3: Nuclei quality comparison. Good-quality nuclei (left) are round, uniformly bright, and well-separated. Poor-quality nuclei (right) show irregular shapes, dim fluorescence, fragmentation, and background debris that can interfere with droplet-based snRNA-seq platforms.

For reference, 10x Genomics recommends targeting >70% viable nuclei with <5% clumps for their Chromium platform when using nuclei from frozen tissue. More stringent targets apply for projects requiring deep sequencing or rare cell-type detection.

Getting Samples to the Lab

Shipping frozen tissue for snRNA-seq follows standard frozen specimen transport rules, with a few project-specific considerations.

Temperature maintenance. Samples must stay frozen during transit — which means enough dry ice to last the entire shipping duration plus a 24-hour buffer. A typical domestic overnight shipment needs 5–10 lbs of dry ice in an insulated container. International shipments require correspondingly more and must comply with IATA dry ice regulations (UN 1845). Temperature loggers inside the shipment are strongly recommended — they provide a record that the cold chain was maintained and are invaluable if results are unexpectedly poor.

Packaging. Double-bag each sample. Place cryovials or cryobags inside a secondary container (a zip-lock bag or a 50 mL conical tube works) to contain any leakage if a tube cracks at low temperature. Label everything clearly — sample IDs, tissue type, storage history if known, and contact information. Include a printed manifest inside the outer box in case external labels are damaged.

Timing. Ship early in the week to avoid weekend holdovers at shipping hubs. Notify the receiving lab ahead of time with tracking information and expected arrival.

For CD Genomics spatial omics sample submission requirements, see the Sample Submission Guidelines page, which covers additional documentation and packaging standards.

Sample Readiness Checklist

Before shipping frozen tissue for snRNA-seq, run through this checklist. A "no" on any item does not necessarily disqualify your samples, but it should prompt a conversation with the processing lab.

When to Ask for a Feasibility Review

If your samples fall outside the straightforward case — consistent −80 °C storage, no freeze-thaw, standard tissue type, adequate amount — request a feasibility review before shipping. A review typically covers:

• Whether the storage history and tissue type are compatible with the lab's nuclei isolation protocol
• Whether additional steps (debris removal, gradient purification, adjusted lysis conditions) are indicated
• Whether a small-scale test isolation is recommended before committing the full sample set
• What nuclei yield, viability, and clumping rate are realistic targets for similar samples the lab has processed

A feasibility review does not guarantee success, but it prevents the most common failure modes — samples arriving without enough dry ice, tissue amounts too small for the platform minimum, or surprise debris that the standard protocol cannot handle.

To discuss your project, visit the snRNA Sequencing Services page or inquire about Single-cell Sequencing Service options that integrate with your tissue-based research.

FAQs

Q1: Can I use frozen tissue that has been stored at −20 °C for snRNA-seq?

A: It is riskier than −80 °C storage. RNA degradation may occur, so only consider if −80 °C storage was not possible. Quality checks are recommended before proceeding.

Q2: How do multiple freeze-thaw cycles affect my samples?

A: Repeated freeze-thaw cycles damage nuclei and increase debris, reducing yield and affecting data quality. Limit freeze-thaw events whenever possible.

Q3: How much tissue is needed for snRNA-seq?

A: Typically 10–50 mg of frozen tissue is sufficient to yield 5,000–10,000 nuclei. Denser tissues require less, while matrix-rich tissues need more.

Q4: How can I tell if nuclei are intact?

A: Use fluorescent staining (e.g., DAPI) and a hemocytometer or automated counter. >80% intact nuclei is a reasonable target for most projects.

Q5: What are the key precautions for shipping frozen tissue?

A: Maintain temperature with sufficient dry ice, double-bag samples, include a printed manifest, and ship early in the week to avoid delays.

Q6: Are there tissues that are especially difficult for nuclei isolation?

A: Yes, lipid-rich tissues (adipose, breast) and fibrotic tissues (pancreas, liver) are challenging. Necrotic regions can also compromise results.

Q7: What should I do if my samples fall outside recommended conditions?

A: Request a feasibility review. The lab may suggest additional steps such as debris removal, adjusted lysis conditions, or small-scale test isolations.

References

1. Denisenko E, Guo BB, Jones M, et al. Systematic assessment of tissue dissociation and storage biases in single-cell and single-nucleus RNA-seq workflows. Genome Biology. 2020;21:130. https://genomebiology.biomedcentral.com/articles/10.1186/s13059-020-02048-6
2. Slyper M, Porter CBM, Ashenberg O, et al. A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nature Medicine. 2020;26:792-802. https://www.nature.com/articles/s41591-020-0844-1
3. 10x Genomics. Nuclei Isolation from Frozen Tissue for Single Nuclei RNA Sequencing — Demonstrated Protocol. 2024. https://www.10xgenomics.com/support/universal-three-prime-gene-expression/documentation/steps/sample-prep/isolation-of-nuclei-for-single-cell-rna-sequencing-and-tissues-for-single-cell-rna-sequencing
4. Ontario Tumour Bank. RNA and DNA Integrity Remain Stable in Frozen Tissue After Long-Term Storage at Cryogenic Temperatures. Biopreservation and Biobanking. 2019;17(4). https://journals.sagepub.com/doi/10.1089/bio.2018.0095
5. Kellman BP, Baghdassarian HM, Pramparo T, et al. Multiple freeze-thaw cycles lead to a loss of consistency in poly(A)-enriched RNA sequencing. BMC Genomics. 2021;22:69. https://link.springer.com/article/10.1186/s12864-021-07381-z
6. Bakken TE, Hodge RD, Miller JA, et al. Single-nucleus and single-cell transcriptomes compared in matched cortical cell types. PLOS ONE. 2018;13(12):e0209648. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0209648
7. Whytock KL, Pino MF, Sun Y, et al. Isolation of nuclei from frozen human subcutaneous adipose tissue for single-nucleus RNA sequencing. STAR Protocols. 2023;4(1):102054. https://pmc.ncbi.nlm.nih.gov/articles/PMC9876942/